Cargando…
MicroRNA-181a/b: Novel biomarkers to stratify breast cancer patients for PARPi treatment
Autores principales: | Mori, Federica, Strano, Sabrina, Blandino, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3735693/ https://www.ncbi.nlm.nih.gov/pubmed/23759567 http://dx.doi.org/10.4161/cc.25173 |
Ejemplares similares
-
Gender, mutant p53 and PML: A growing “affaire” in tumor suppression and oncogenesis
por: Di Agostino, Silvia, et al.
Publicado: (2013) -
The lin-4 microRNA: The ultimate micromanager
por: Esquela-Kerscher, Aurora
Publicado: (2014) -
Milking the stroma in triple-negative breast cancer
por: Thompson, Alastair M., et al.
Publicado: (2012) -
GSK-3β: A key regulator of breast cancer drug resistance
por: Martelli, Alberto M, et al.
Publicado: (2014) -
Senescence-associated lysosomal α-L-fucosidase (SA-α-Fuc): A sensitive and more robust biomarker for cellular senescence beyond SA-β-Gal
por: Singh, Madhurendra, et al.
Publicado: (2013)